Roger Song
Stock Analyst at Jefferies
(1.87)
# 3,159
Out of 4,947 analysts
49
Total ratings
38.46%
Success rate
-8.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences | Assumes: Buy | $36 | $14.72 | +144.65% | 1 | Aug 15, 2025 | |
| LVTX LAVA Therapeutics | Downgrades: Hold | $3 → $1.5 | $1.52 | -1.32% | 1 | Aug 5, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $45 → $54 | $33.38 | +61.77% | 3 | Jul 29, 2025 | |
| REPL Replimune Group | Maintains: Buy | $31 → $6 | $5.56 | +7.91% | 2 | Jul 22, 2025 | |
| CVAC CureVac | Downgrades: Hold | $7 → $5 | $5.48 | -8.76% | 1 | Jun 13, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $15 → $30 | $27.26 | +10.05% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $3.25 | +84.62% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $3.33 | +110.21% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $150.27 | +63.04% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $9.76 | +166.39% | 1 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $48 → $2 | $1.27 | +57.48% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $42 → $7 | $4.55 | +53.85% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $28 | $7.34 | +281.47% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.87 | +274.33% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $59.86 | +48.68% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $9.58 | +160.96% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $10.58 | +287.52% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $16.82 | +108.09% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.90 | +83.67% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $32.70 | +294.50% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $1.91 | +318.85% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $76.04 | +27.56% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $22.57 | +219.01% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $40.03 | +174.79% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $3.63 | +864.19% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.87 | +934.48% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $5.43 | +47.33% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.88 | +2,291.80% | 1 | Sep 2, 2020 |
MBX Biosciences
Aug 15, 2025
Assumes: Buy
Price Target: $36
Current: $14.72
Upside: +144.65%
LAVA Therapeutics
Aug 5, 2025
Downgrades: Hold
Price Target: $3 → $1.5
Current: $1.52
Upside: -1.32%
Kiniksa Pharmaceuticals International,
Jul 29, 2025
Maintains: Buy
Price Target: $45 → $54
Current: $33.38
Upside: +61.77%
Replimune Group
Jul 22, 2025
Maintains: Buy
Price Target: $31 → $6
Current: $5.56
Upside: +7.91%
CureVac
Jun 13, 2025
Downgrades: Hold
Price Target: $7 → $5
Current: $5.48
Upside: -8.76%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $15 → $30
Current: $27.26
Upside: +10.05%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $3.25
Upside: +84.62%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $3.33
Upside: +110.21%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $150.27
Upside: +63.04%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $9.76
Upside: +166.39%
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.27
Upside: +57.48%
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.55
Upside: +53.85%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $7.34
Upside: +281.47%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.87
Upside: +274.33%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $59.86
Upside: +48.68%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $9.58
Upside: +160.96%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $10.58
Upside: +287.52%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $16.82
Upside: +108.09%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $4.90
Upside: +83.67%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $32.70
Upside: +294.50%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $1.91
Upside: +318.85%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $76.04
Upside: +27.56%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $22.57
Upside: +219.01%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $40.03
Upside: +174.79%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $3.63
Upside: +864.19%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.87
Upside: +934.48%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $5.43
Upside: +47.33%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.88
Upside: +2,291.80%